Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population

CONCLUSIONS: Various palbociclib-based regimens have promising efficacy in ER+ metastatic breast cancer in real-world settings, even in patients who had been pre-treated with everolimus.PMID:35984107 | DOI:10.1097/CM9.0000000000002240
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research